Spinnaker Capital’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.08M Hold
175,384
100% 1
2024
Q4
$1.42M Hold
175,384
100% 1
2024
Q3
$1.42M Hold
175,384
100% 1
2024
Q2
$759K Hold
175,384
100% 1
2024
Q1
$744K Hold
175,384
100% 1
2023
Q4
$659K Hold
175,384
100% 1
2023
Q3
$649K Hold
175,384
100% 1
2023
Q2
$695K Hold
175,384
100% 1
2023
Q1
$726K Hold
175,384
100% 1
2022
Q4
$740K Hold
175,384
100% 1
2022
Q3
$496K Hold
175,384
100% 1
2022
Q2
$705K Hold
175,384
100% 1
2022
Q1
$961K Hold
175,384
100% 1
2021
Q4
$798K Hold
175,384
15.31% 2
2021
Q3
$816K Hold
175,384
1.09% 2
2021
Q2
$1.2M Hold
175,384
1.49% 2
2021
Q1
$1.75M Buy
175,384
+95,000
+118% +$1M 2.16% 2
2020
Q4
$597K Hold
80,384
0.56% 2
2020
Q3
$485K Hold
80,384
0.67% 2
2020
Q2
$506K Hold
80,384
0.6% 2
2020
Q1
$289K Hold
80,384
0.46% 2
2019
Q4
$585K Hold
80,384
0.5% 2
2019
Q3
$513K Hold
80,384
0.39% 2
2019
Q2
$721K Hold
80,384
0.38% 2
2019
Q1
$760K Hold
80,384
0.26% 2
2018
Q4
$518K Hold
80,384
0.18% 2
2018
Q3
$389K Hold
80,384
0.08% 3
2018
Q2
$95K Hold
80,384
0.03% 3
2018
Q1
$73K Hold
80,384
0.01% 3
2017
Q4
$202K Buy
+80,384
New +$231K 0.05% 3

Other funds holding CRMD

Spinnaker Capital's CRMD Position: Q1 2025 in Review

Spinnaker Capital held its CorMedix (CRMD) position steady in Q1 2025 at 175,384 shares worth $1.08M. The position accounts for 100% of the portfolio, ranked #1.

Spinnaker Capital first reported a position in CRMD in Q4 2017 and has held it in 30 quarters since. The position peaked at $1.75M in Q1 2021. 137 funds tracked by Wall St. Rank hold CRMD as of Q1 2025.

  • Spinnaker Capital held 175,384 shares of CorMedix worth $1.08M as of Q1 2025.
  • Spinnaker Capital left its CorMedix share count unchanged in Q1 2025.
  • CorMedix made up 100% of Spinnaker Capital's portfolio in Q1 2025, its #1 holding.
  • Spinnaker Capital first reported a position in CorMedix in Q4 2017 and has held it in 30 quarters since.
  • Spinnaker Capital's CorMedix position peaked at $1.75M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held CorMedix as of Q1 2025.

Based on Spinnaker Capital's 13F filing for Q1 2025, filed 15 May 2025.